Imaging Device for Glaucoma

Recruiting in Palo Alto (17 mi)

+1 other location

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Optos, PLC

No Placebo Group

Trial Summary

What is the purpose of this trial?

Images captured on the P200TE device on glaucoma patients

Eligibility Criteria

This trial is for adults aged 22 or older with glaucoma, having a visual acuity of 20/40 or better in the study eye. Participants must have had visual field defects consistent with glaucoma within the last year and be able to give informed consent. Those with other eye diseases, poor tolerance for ophthalmic imaging, or unclear ocular media are excluded.

Inclusion Criteria

BCVA 20/40 or better in the study eye

I was at least 22 years old when I gave my consent.

I understand and agree to participate in the study by signing the consent form.

See 1 more

Exclusion Criteria

My study eye has no eye diseases except possibly glaucoma.

Subjects unable to tolerate ophthalmic imaging

Subject has a condition or is in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study

See 2 more

Treatment Details

Interventions

P200TE (Procedure)

Trial OverviewThe P200TE device is being tested to capture images from patients with glaucoma. The goal is to evaluate how well this device works in detecting and assessing changes related to glaucoma by analyzing optic nerve damage through captured images.

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Imaging DeviceExperimental Treatment1 Intervention

Various scans will be captured